These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 30396825)

  • 41. The opioid crisis: Origins, trends, policies, and the roles of pharmacists.
    Chisholm-Burns MA; Spivey CA; Sherwin E; Wheeler J; Hohmeier K
    Am J Health Syst Pharm; 2019 Mar; 76(7):424-435. PubMed ID: 31361827
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A standardized team-based approach for identifying naloxone-eligible patients in a grocery store pharmacy.
    Sexton SM; Armstrong A; Gatton O; Rhodes LA; Marciniak MW
    J Am Pharm Assoc (2003); 2019; 59(4S):S95-S100. PubMed ID: 31231001
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Indian Health Service pharmacists engaged in opioid safety initiatives and expanding access to naloxone.
    Duvivier H; Gustafson S; Greutman M; Jangchup T; Harden AK; Reinhard A; Warshany K
    J Am Pharm Assoc (2003); 2017; 57(2S):S135-S140. PubMed ID: 28292501
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Patient acceptance of naloxone resulting from targeted intervention from community pharmacists to prevent opioid misuse and accidental overdose.
    Skoy E; Werremeyer A; Steig J; Eukel H; Frenzel O; Strand M
    Subst Abus; 2021; 42(4):672-677. PubMed ID: 33044896
    [No Abstract]   [Full Text] [Related]  

  • 45. Opioid overdose prevention through pharmacy-based naloxone prescription program: Innovations in health care delivery.
    Bachyrycz A; Shrestha S; Bleske BE; Tinker D; Bakhireva LN
    Subst Abus; 2017; 38(1):55-60. PubMed ID: 27164192
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Changes in Pharmacists' Perceptions After a Training in Opioid Misuse and Accidental Overdose Prevention.
    Eukel HN; Skoy E; Werremeyer A; Burck S; Strand M
    J Contin Educ Health Prof; 2019; 39(1):7-12. PubMed ID: 30614959
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacists' role in opioid overdose: Kentucky pharmacists' willingness to participate in naloxone dispensing.
    Freeman PR; Goodin A; Troske S; Strahl A; Fallin A; Green TC
    J Am Pharm Assoc (2003); 2017; 57(2S):S28-S33. PubMed ID: 28139459
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Implementation and assessment of a pilot, community pharmacy-based, opioid pain medication management program.
    Manzur V; Mirzaian E; Huynh T; Lien A; Ly K; Wong H; Wang M; Lou M; Durham M
    J Am Pharm Assoc (2003); 2020; 60(3):497-502. PubMed ID: 31926871
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 'Making the invisible visible' through alcohol screening and brief intervention in community pharmacies: an Australian feasibility study.
    Hattingh HL; Hallett J; Tait RJ
    BMC Public Health; 2016 Nov; 16(1):1141. PubMed ID: 27825369
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Considering pharmacy workflow in the context of Australian community pharmacy: A pilot time and motion study.
    Cavaye D; Lehnbom EC; Laba TL; El-Boustani E; Joshi R; Webster R
    Res Social Adm Pharm; 2018 Dec; 14(12):1157-1162. PubMed ID: 29317188
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Risk-based strategy for outpatient pharmacy practice: Focus on opioids.
    Holdsworth MT; Benson BE; Dole EJ
    J Am Pharm Assoc (2003); 2015; 55(5):553-6. PubMed ID: 26208290
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Implementation of academic detailing for pharmacists on opioid use disorder and harm reduction.
    DiPaula BA; Cooke CE; Boyle CJ; Love RC
    J Am Pharm Assoc (2003); 2022; 62(1):241-246. PubMed ID: 34690080
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nonprescription naloxone and syringe sales in the midst of opioid overdose and hepatitis C virus epidemics: Massachusetts, 2015.
    Stopka TJ; Donahue A; Hutcheson M; Green TC
    J Am Pharm Assoc (2003); 2017; 57(2S):S34-S44. PubMed ID: 28189540
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Using the behaviour change wheel to understand and address barriers to pharmacy naloxone supply in Australia.
    Nielsen S; Olsen A
    Int J Drug Policy; 2021 Apr; 90():103061. PubMed ID: 33321285
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of the RESPOND Toolkit on community pharmacists' opioid safety attitudes, self-efficacy, and knowledge.
    Irwin AN; Novak K; Alley L; Havlin T; O'Kane N; Johnston K; Hildebran C; Carson J; Hartung DM
    J Am Pharm Assoc (2003); 2020; 60(3):450-455.e3. PubMed ID: 31919007
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A pilot evaluation of incorporating "opt-out" naloxone dispensing within a chain community pharmacy.
    Skoy E
    Res Social Adm Pharm; 2019 Aug; 15(8):1043-1046. PubMed ID: 30473398
    [No Abstract]   [Full Text] [Related]  

  • 57. Community Pharmacists' Perspectives on Dispensing Medications With the Potential for Misuse, Diversion, and Intentional Overdose: Results of a Province-Wide Survey of Community Pharmacists in Canada.
    Leong C; Alessi-Severini S; Sareen J; Enns MW; Bolton J
    Subst Use Misuse; 2016 Nov; 51(13):1724-30. PubMed ID: 27487323
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development and delivery of a pharmacist training program to increase naloxone access in Kentucky.
    Palmer E; Hart S; Freeman PR
    J Am Pharm Assoc (2003); 2017; 57(2S):S118-S122. PubMed ID: 28161300
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Community pharmacist workflow: Space for Pharmacy-based Interventions and Consultation TimE study protocol.
    Karia AM; Balane C; Norman R; Robinson S; Lehnbom E; Durakovic I; Laba TL; Joshi R; Webster R
    Int J Pharm Pract; 2020 Oct; 28(5):441-448. PubMed ID: 32347607
    [TBL] [Abstract][Full Text] [Related]  

  • 60. How does use of a prescription monitoring program change pharmacy practice?
    Green TC; Mann MR; Bowman SE; Zaller N; Soto X; Gadea J; Cordy C; Kelly P; Friedmann PD
    J Am Pharm Assoc (2003); 2013; 53(3):273-81. PubMed ID: 23699676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.